Novartis AGNVSNYSE
Loading
Research and development spending
3Y CAGR
+5.4%/yr
vs +2.0%/yr prior
5Y CAGR
+3.6%/yr
Consistent
Acceleration
+3.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.74B | +7.2% |
| 2024 | $10.02B | -11.9% |
| 2023 | $11.37B | +24.0% |
| 2022 | $9.17B | +6.1% |
| 2021 | $8.64B | -3.8% |
| 2020 | $8.98B | -4.5% |
| 2019 | $9.40B | +10.8% |
| 2018 | $8.49B | +1.2% |
| 2017 | $8.39B | -7.2% |
| 2016 | $9.04B | - |